344 related articles for article (PubMed ID: 18095232)
1. Optimizing therapy for Candida infections.
Playford EG; Sorrell TC
Semin Respir Crit Care Med; 2007 Dec; 28(6):678-88. PubMed ID: 18095232
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological advances in the treatment of invasive candidiasis.
Deck DH; Guglielmo BJ
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):137-49. PubMed ID: 16441215
[TBL] [Abstract][Full Text] [Related]
3. Antifungals in the ICU.
Playford EG; Eggimann P; Calandra T
Curr Opin Infect Dis; 2008 Dec; 21(6):610-9. PubMed ID: 18978529
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
5. Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region.
Hsueh PR; Graybill JR; Playford EG; Watcharananan SP; Oh MD; Ja'alam K; Huang S; Nangia V; Kurup A; Padiglione AA
Int J Antimicrob Agents; 2009 Sep; 34(3):205-9. PubMed ID: 19409759
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility patterns of Candida species recovered from Canadian intensive care units.
Laverdiere M; Labbé AC; Restieri C; Rotstein C; Heyland D; Madger S; Stewart T
J Crit Care; 2007 Sep; 22(3):245-50. PubMed ID: 17869976
[TBL] [Abstract][Full Text] [Related]
7. Candida prophylaxis and therapy in the ICU.
Echeverria PM; Kett DH; Azoulay E
Semin Respir Crit Care Med; 2011 Apr; 32(2):159-73. PubMed ID: 21506052
[TBL] [Abstract][Full Text] [Related]
8. Management of candidiasis in the intensive care unit.
Schelenz S
J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i31-4. PubMed ID: 18063602
[TBL] [Abstract][Full Text] [Related]
9. Resistance to antifungal agents in the critical care setting: problems and perspectives.
Martins MD; Rex JH
New Horiz; 1996 Aug; 4(3):338-44. PubMed ID: 8856751
[TBL] [Abstract][Full Text] [Related]
10. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital.
Muñoz P; Sánchez-Somolinos M; Alcalá L; Rodríguez-Créixems M; Peláez T; Bouza E
J Antimicrob Chemother; 2005 Feb; 55(2):188-93. PubMed ID: 15650001
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiological study of invasive nosocomial candidiasis in 2 teaching hospitals in Beijing].
Cao B; Wang H; Wu L; Sun WJ; Li F; Liu YM
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1970-3. PubMed ID: 19062737
[TBL] [Abstract][Full Text] [Related]
12. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
[TBL] [Abstract][Full Text] [Related]
13. Candida endophthalmitis: focus on current and future antifungal treatment options.
Khan FA; Slain D; Khakoo RA
Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891
[TBL] [Abstract][Full Text] [Related]
14. Clinical consequences of resistant Candida infections in intensive care.
Montravers P; Jabbour K
Int J Antimicrob Agents; 2006 Jan; 27(1):1-6. PubMed ID: 16343859
[TBL] [Abstract][Full Text] [Related]
15. Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - Trends over 10 years.
Bailly S; Maubon D; Fournier P; Pelloux H; Schwebel C; Chapuis C; Foroni L; Cornet M; Timsit JF
J Infect; 2016 Jan; 72(1):103-11. PubMed ID: 26518058
[TBL] [Abstract][Full Text] [Related]
16. Is Candida really a threat in the ICU?
Blot S; Dimopoulos G; Rello J; Vogelaers D
Curr Opin Crit Care; 2008 Oct; 14(5):600-4. PubMed ID: 18787456
[TBL] [Abstract][Full Text] [Related]
17. A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.
Diekema DJ; Messer SA; Hollis RJ; Boyken L; Tendolkar S; Kroeger J; Jones RN; Pfaller MA
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):233-6. PubMed ID: 19070452
[TBL] [Abstract][Full Text] [Related]
18. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.
Kim MN; Shin JH; Sung H; Lee K; Kim EC; Ryoo N; Lee JS; Jung SI; Park KH; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
Clin Infect Dis; 2009 Mar; 48(6):e57-61. PubMed ID: 19193113
[TBL] [Abstract][Full Text] [Related]
19. Candida glabrata fungaemia in intensive care units.
Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
